Analytical approaches in microRNA therapeutics

被引:14
作者
Batkai, Sandor [1 ]
Thum, Thomas [1 ,2 ]
机构
[1] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2014年 / 964卷
关键词
MicroRNA; Oligonucleotide; Purification; Functional assay; Biomarker; Liquid chromatography-mass spectrometry; SMALL INTERFERING RNA; PERFORMANCE LIQUID-CHROMATOGRAPHY; CHAIN-REACTION PRODUCTS; MASS-SPECTROMETRY; CIRCULATING MICRORNAS; IN-VIVO; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; MYOCARDIAL-INFARCTION; POTENTIAL BIOMARKER; NUCLEIC-ACIDS;
D O I
10.1016/j.jchromb.2014.03.027
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
MicroRNAs are non-coding oligonucleotides with regulatory roles in virtually all biological processes. Deregulation of microRNAs lead to impaired cellular function and disease development. Thus, microRNAs are of potential diagnostic and therapeutic relevance. Several technology platforms are currently available for quantitative microRNA analysis and profiling, including the most extensively used PCR-based methods. Each of these technologies has its own advantages and limitations. Mass spectrometry combines low-level detectability with high selectivity and has been used for oligonucleotide sequence analysis. Its use for native microRNA analysis has been limited due to the very low abundance and chemical similarity of microRNAs. However, with the advancement of technology, this analytical method has become a powerful complementary tool for comprehensive analysis of native and synthetic microRNAs. This brief review highlights current developments in the field of microRNA analytics, detection techniques for extracellular microRNAs, their synthetic inhibitors, and the dynamics of their interactions. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:146 / 152
页数:7
相关论文
共 74 条
[1]
Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction [J].
Adachi, Taichi ;
Nakanishi, Michio ;
Otsuka, Yoritaka ;
Nishimura, Kunihiro ;
Hirokawa, Gou ;
Goto, Yoichi ;
Nonogi, Hiroshi ;
Iwai, Naoharu .
CLINICAL CHEMISTRY, 2010, 56 (07) :1183-1185
[2]
Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction [J].
Ai, Jing ;
Zhang, Rong ;
Li, Yue ;
Pu, Jielin ;
Lu, Yanjie ;
Jiao, Jundong ;
Li, Kang ;
Yu, Bo ;
Li, Zhuqin ;
Wang, Rongrong ;
Wang, Lihong ;
Li, Qiang ;
Wang, Nina ;
Shan, Hongli ;
Li, Zhongyu ;
Yang, Baofeng .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) :73-77
[3]
The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[4]
Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver [J].
Androsavich, John R. ;
Chau, B. Nelson ;
Bhat, Balkrishen ;
Linsley, Peter S. ;
Walter, Nils G. .
RNA, 2012, 18 (08) :1510-1526
[5]
[Anonymous], 2013, Chem. Rev
[6]
Analysis of oligonucleotides by HPLC-electrospray ionization mass spectrometry [J].
Apffel, A ;
Chakel, JA ;
Fischer, S ;
Lichtenwalter, K ;
Hancock, WS .
ANALYTICAL CHEMISTRY, 1997, 69 (07) :1320-1325
[7]
Neutrally charged phosphorodiamidate morpholino antisense oligomers: Uptake, efficacy and pharmacokinetics [J].
Arora, V ;
Devi, GR ;
Iversen, PL .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2004, 5 (05) :431-439
[8]
Biogenesis and Regulation of Cardiovascular MicroRNAs [J].
Bauersachs, Johann ;
Thum, Thomas .
CIRCULATION RESEARCH, 2011, 109 (03) :334-347
[9]
Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available [J].
Benes, Vladimir ;
Castoldi, Mirco .
METHODS, 2010, 50 (04) :244-249
[10]
Bramsen JB, 2011, METHODS MOL BIOL, V721, P77, DOI 10.1007/978-1-61779-037-9_5